SCHEMBL28028310

SCHEMBL28028310

Nn1cccc1NC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28266002 0.74
SCHEMBL28194790 0.74
SCHEMBL27985186 0.71 ALDH1A1 (0.35)
SCHEMBL28295721 0.68 ALDH1A1 (0.33)
SCHEMBL1703803 0.65
Pyridine SCHEMBL28875144 0.65 TRIM24 (0.39)
SCHEMBL28302067 0.63 IDH1 (0.43)
SCHEMBL12129057 0.59 ALDH1A1 (0.67)
SCHEMBL28947850 0.58 ALDH1A1 (0.34)
SCHEMBL27981770 0.58 ALDH1A1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108218874-B Phosphodiesterase inhibitor and application thereof 南京药捷安康生物科技有限公司 2020-10-30 CN disclosed
CN-104876935-B 2-aminopyrrolo[1,2-f][1,2,4]triazine compounds, and synthesis method and application thereof 南方医科大学 2017-04-19 CN disclosed
CN-104876935-A 2-aminopyrrolo[1,2-f][1,2,4]triazine compounds, and synthesis method and application thereof UNIV SOUTHERN MEDICAL 2015-09-02 CN disclosed